Legend Biotech Corporation
LEGN
Jodie situation report
Legend Biotech Corporation's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- LEGN's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if LEGN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind LEGN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
CABACabaletta Bio, Inc.partnerMar 23, 2026 ▾
“Our Chief Commercial Officer, Steve Gavel, joined Cabaletta in October 2025 and was previously Senior Vice President, Global Cell Therapy Commercial Development at Legend Biotech from 2018 to 2025, reporting to the CEO, where he created and scaled its commerc…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
LEGN is currently a Leader in the organic co-movement group CAR-T Cancer Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for LEGN; it is not active in the latest market snapshot.